6H47

Human KRAS in complex with darpin K19

6H47 の概要

• エントリーDOI: 10.2210/pdb6h47/pdb
• 分子名称: GTPase KRas, darpin K19, SULFATE ION, ... (4 entities in total)
• 機能のキーワード: gtp-ase, darpin, kras signalling, signaling protein
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 39158.93

構造登録者

Debreczeni, J.E.,Bery, N.,Legg, S.,Breed, J.,Embrey, K.,Stubbs, C.,Kolasinska-Zwierz, P.,Barrett, N.,Marwood, R.,Watson, J.,Tart, J.,Overman, R.,Miller, A.,Phillips, C.,Minter, R.,Rabbitts, T.H. (登録日: 2018-07-20, 公開日: 2019-04-24, 最終更新日: 2024-05-15)

主引用文献

Bery, N.,Legg, S.,Debreczeni, J.,Breed, J.,Embrey, K.,Stubbs, C.,Kolasinska-Zwierz, P.,Barrett, N.,Marwood, R.,Watson, J.,Tart, J.,Overman, R.,Miller, A.,Phillips, C.,Minter, R.,Rabbitts, T.H.
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe.
Nat Commun, 10:2607-2607, 2019

PubMed Abstract: Inhibiting the RAS oncogenic protein has largely been through targeting the switch regions that interact with signalling effector proteins. Here, we report designed ankyrin repeat proteins (DARPins) macromolecules that specifically inhibit the KRAS isoform by binding to an allosteric site encompassing the region around KRAS-specific residue histidine 95 at the helix α3/loop 7/helix α4 interface. We show that these DARPins specifically inhibit KRAS/effector interactions and the dependent downstream signalling pathways in cancer cells. Binding by the DARPins at that region influences KRAS/effector interactions in different ways, including KRAS nucleotide exchange and inhibiting KRAS dimerization at the plasma membrane. These results highlight the importance of targeting the α3/loop 7/α4 interface, a previously untargeted site in RAS, for specifically inhibiting KRAS function.

PubMed: 31197133
DOI: 10.1038/s41467-019-10419-2

実験手法

X-RAY DIFFRACTION (1.7 Å)